Nov 152016
 
 November 15, 2016  Court, Govt, Healthcare, Surveillance

Here’s the latest development in a case I’ve been following on this site. Karen Owen Gibbs and Patrick Callaghan of McDermott Will & Emery write:

On November 7, 2016, the US Court of Appeals for the Ninth Circuit heard arguments in Oregon Prescription Drug Monitoring Program v. United States DEA, Case No. 14-35402 (9th Cir. 2016). The Drug Enforcement Administration (DEA) sought to overturn a US District Court for the District of Oregon ruling that the DEA’s use of administrative subpoenas to access records from the Prescription Drug Monitoring Program (PDMP) violates the Fourth Amendment (the District Court Case).

The case has potentially wide-ranging implications.

Read more on National Law Review.

Sorry, the comment form is closed at this time.